CAS 1047644-62-1
:Afuresertib
Description:
Afuresertib is a small molecule inhibitor primarily targeting the protein kinase AKT, which plays a crucial role in various cellular processes, including metabolism, proliferation, and survival. It is classified as a selective inhibitor, demonstrating potential therapeutic applications in oncology, particularly for cancers with aberrant AKT signaling pathways. The compound is characterized by its ability to interfere with the phosphorylation of downstream targets of AKT, thereby inhibiting tumor growth and promoting apoptosis in cancer cells. Afuresertib is typically administered in a clinical setting, and its efficacy is often evaluated in combination with other therapeutic agents. The substance is known for its moderate solubility in organic solvents and has a specific molecular structure that contributes to its biological activity. As with many targeted therapies, the pharmacokinetics and pharmacodynamics of Afuresertib are critical for determining its clinical utility, including its absorption, distribution, metabolism, and excretion profiles. Ongoing research continues to explore its potential in various cancer types and its role in personalized medicine approaches.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Afuresertib
CAS:<p>Afuresertib (GSK2110183) is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic</p>Formula:C18H17Cl2FN4OSPurity:97.51% - 99.51%Color and Shape:SolidMolecular weight:427.32Afuresertib
CAS:<p>Inhibitor of pan-AKT</p>Formula:C18H17Cl2FN4OSPurity:Min. 95%Molecular weight:427.32 g/mol
